US · biotech · biotechnology · healthcare
2 rounds we have observed, with the investors named in each. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Oct 2025 · $600M
Bain Capital Private Equity lead, Qatar Investment Authority, CPP Investments, Adage Capital Management, Royalty Pharma
Reported by Crunchbase News and 1 other
Missing a round, or an investor who was in one? Tell us.